Form 4: Itron CEO Thomas Deitrich Executes Pre-Arranged Stock Option Exercise and Share Sale

Itron's President and CEO, Thomas Deitrich, executed a pre-arranged transaction on June 4, 2025, exercising stock options and subsequently selling an equivalent number of shares for approximately $4.25 million under a Rule 10b5-1 trading plan.

Summary

• Thomas Deitrich, President & CEO and Director of Itron, Inc. (ITRI), engaged in a pre-planned transaction on June 4, 2025, under a Rule 10b5-1 trading plan adopted on March 4, 2025.
• He exercised stock options to acquire 35,461 shares of common stock at an exercise price of $40.05 per share. These options had fully vested on February 24, 2019, and are set to expire on February 24, 2026.
• Immediately following the exercise, Mr. Deitrich sold all 35,461 shares of common stock.
• The sales occurred in two tranches: 31,751 shares at a weighted average price of $119.6602 per share (ranging from $119.2650 to $119.9950) and 3,710 shares at a weighted average price of $120.1645 per share (ranging from $120.0050 to $120.4800).
• The total proceeds from the sale of 35,461 shares amount to approximately $4,250,000.
• Following these transactions, Mr. Deitrich directly holds 262,028 shares of common stock and indirectly holds 25,000 shares through a trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale can sometimes be viewed negatively, the execution under a Rule 10b5-1 plan mitigates concerns about opportunistic selling. The significant profit from the option exercise reflects positively on the company's stock performance over time.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new, non-public information.
• The significant difference between the exercise price ($40.05) and the sale prices (approximately $120) indicates a substantial gain for the insider, reflecting past stock appreciation.

Negatives

• The sale of shares by a senior executive, even under a 10b5-1 plan, represents a reduction in direct insider ownership, which some investors might interpret as a lack of confidence, although it is a common practice for diversification and liquidity.

Future Outlook

NA

Industry Context

This Form 4 filing details an executive's pre-planned stock transactions, which is a routine disclosure in the financial industry. It does not provide specific insights into broader industry trends or competitive landscape beyond the company's stock performance implied by the sale price.

Stakeholder Impact

• Shareholders: The sale by a key executive might be viewed with slight caution, but the pre-planned nature (10b5-1) generally reduces negative implications. The substantial profit from the options exercise highlights the value creation for long-term shareholders.

Key Dates

Recommendation

Keywords

Itron, ITRI, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, Executive Compensation, Thomas Deitrich, Common Stock